1. P875: ACTIVATION OF LNCRNA NEAT1 LEADS TO SURVIVAL ADVANTAGE OF MULTIPLE MYELOMA CELLS BY SUPPORTING A REGULATORY LOOP WITH DNA REPAIR PROTEINS: RATIONAL BASES FOR NEAT1 THERAPEUTIC TARGETING IN THE DISEASE. (23rd June 2022) Authors: Taiana, E.; Ronchetti, D.; Favasuli, V. K.; Silvestris, I.; Puccio, N.; Todoerti, K.; Bandini, C.; Craparotta, I.; Di Rito, L.; Erratico, S.; Giannandrea, D.; Piva, R.; Bolis, M.; Torrente, Y.; Chiaramonte, R.; Bolli, N.; Baldini, L.; Neri, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗